Oric Pharmaceuticals, Inc. · NASDAQ:ORIC
Viking Global Investors LP reported a 9.99% stake in Oric Pharmaceuticals, Inc. (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Viking Global Investors LP reported a 9.99% stake in Oric Pharmaceuticals, Inc., 8,729,345 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 9.99%
- Shares
- 8,729,345
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 11 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| VIKING GLOBAL INVESTORS LP | 9.99% | 8,729,345 |
| Viking Global Opportunities Parent GP LLC | 9.99% | 8,729,345 |
| Viking Global Opportunities GP LLC | 6.42% | 5,606,787 |
| Viking Global Opportunities Portfolio GP LLC | 6.42% | 5,606,787 |
| Viking Global Opportunities Illiquid Investments Sub-Master LP | 6.42% | 5,606,787 |
| Viking Global Opportunities Drawdown GP LLC | 3.57% | 3,122,558 |
| Viking Global Opportunities Drawdown Portfolio GP LLC | 3.57% | 3,122,558 |
| Viking Global Opportunities Drawdown (Aggregator) LP | 3.57% | 3,122,558 |
| HALVORSEN OLE ANDREAS | 9.99% | 8,729,345 |
| Ott David C. | 9.99% | 8,729,345 |
| Shabet Rose Sharon | 9.99% | 8,729,345 |
Source
Related
- Oric Pharmaceuticals, Inc.
- Viking Global Investors LP
- Oric Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Viking Global Investors LP · May 15, 2026
- Schedule 13G/A · Viking Global Investors LP · May 15, 2025
- Form 4 · Piscitelli Dominic · Oct 21, 2026
- Form 4 · Heyman Richard A. · Oct 2, 2026
- Form 4 · Piscitelli Dominic · Sep 29, 2026
- Form 4 · Piscitelli Dominic · Sep 25, 2026
- Form 4 · Piscitelli Dominic · Aug 28, 2026